WAVE LIFE SCIENCES LTD's ticker is WVE and the CUSIP is Y95308105. A total of 144 filers reported holding WAVE LIFE SCIENCES LTD in Q2 2024. The put-call ratio across all filers is 1.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $7,183 | -37.5% | 1,439,271 | -22.7% | 0.00% | 0.0% |
| Q1 2024 | $11,485 | +39.7% | 1,861,254 | +14.4% | 0.00% | 0.0% |
| Q4 2023 | $8,219 | +12.6% | 1,627,363 | +28.2% | 0.00% | 0.0% |
| Q3 2023 | $7,299 | +3531.3% | 1,269,162 | +2200.6% | 0.00% | – |
| Q2 2023 | $201 | +26.4% | 55,167 | +50.9% | 0.00% | – |
| Q1 2023 | $159 | +69.1% | 36,559 | +171.6% | 0.00% | – |
| Q4 2022 | $94 | -99.9% | 13,459 | -68.8% | 0.00% | – |
| Q3 2022 | $156,000 | +66.0% | 43,080 | +48.7% | 0.00% | – |
| Q2 2022 | $94,000 | +56.7% | 28,980 | -3.3% | 0.00% | – |
| Q1 2022 | $60,000 | +11.1% | 29,982 | +74.5% | 0.00% | – |
| Q4 2021 | $54,000 | -68.6% | 17,182 | -51.0% | 0.00% | – |
| Q3 2021 | $172,000 | -26.5% | 35,082 | 0.0% | 0.00% | – |
| Q2 2021 | $234,000 | +37.6% | 35,082 | +15.8% | 0.00% | – |
| Q1 2021 | $170,000 | -97.2% | 30,288 | -96.0% | 0.00% | -100.0% |
| Q4 2020 | $6,032,000 | -28.9% | 766,396 | -23.4% | 0.00% | 0.0% |
| Q3 2020 | $8,489,000 | -38.2% | 999,918 | -24.2% | 0.00% | -50.0% |
| Q2 2020 | $13,731,000 | +34.7% | 1,318,982 | +21.3% | 0.00% | 0.0% |
| Q1 2020 | $10,190,000 | +12.9% | 1,087,536 | -3.4% | 0.00% | +100.0% |
| Q4 2019 | $9,023,000 | -49.9% | 1,125,788 | +28.3% | 0.00% | -66.7% |
| Q3 2019 | $18,018,000 | -36.9% | 877,644 | -19.8% | 0.00% | -25.0% |
| Q2 2019 | $28,543,000 | -51.4% | 1,094,013 | -27.7% | 0.00% | -55.6% |
| Q1 2019 | $58,756,000 | -12.4% | 1,512,386 | -5.2% | 0.01% | -18.2% |
| Q4 2018 | $67,075,000 | -20.8% | 1,595,506 | -5.8% | 0.01% | -8.3% |
| Q3 2018 | $84,695,000 | +33.2% | 1,693,892 | +1.9% | 0.01% | +20.0% |
| Q2 2018 | $63,566,000 | -8.8% | 1,661,851 | -4.4% | 0.01% | -9.1% |
| Q1 2018 | $69,697,000 | +15.0% | 1,738,085 | +0.6% | 0.01% | +10.0% |
| Q4 2017 | $60,616,000 | +62.1% | 1,726,956 | +0.4% | 0.01% | +66.7% |
| Q3 2017 | $37,400,000 | +14.5% | 1,719,554 | -2.1% | 0.01% | 0.0% |
| Q2 2017 | $32,662,000 | +144.3% | 1,756,031 | +261.1% | 0.01% | +100.0% |
| Q1 2017 | $13,372,000 | +259.6% | 486,260 | +241.9% | 0.00% | +200.0% |
| Q4 2016 | $3,719,000 | -19.5% | 142,220 | -0.1% | 0.00% | 0.0% |
| Q3 2016 | $4,621,000 | – | 142,320 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 7,512,049 | $287,336,000 | 18.66% |
| BERYLSON CAPITAL PARTNERS, LLC | 162,238 | $6,206,000 | 7.67% |
| Boxer Capital, LLC | 1,590,600 | $60,840,000 | 6.89% |
| New Leaf Venture Partners, L.L.C. | 433,429 | $16,579,000 | 4.00% |
| Redmile Group, LLC | 2,244,507 | $85,852,000 | 2.92% |
| EMORY UNIVERSITY | 67,925 | $2,598,000 | 1.72% |
| EcoR1 Capital, LLC | 412,871 | $15,792,000 | 1.50% |
| BB BIOTECH AG | 1,137,885 | $43,524,000 | 1.26% |
| BRIDGER MANAGEMENT, LLC | 562,615 | $21,520,000 | 1.17% |
| Matisse Capital | 37,234 | $1,424,000 | 1.13% |